Cytokeratin Antibody, anti-human, FITC 130-119-141 from Miltenyi Biotec

Product Specs
ItemCytokeratin Antibody, anti-human, FITC
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-119-141
Quantity30 tests in 60 µL
ApplicationsIntracellular flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
Concentration1:50
Conjugate/TagFITC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
IsotypeIgG1
CloneCK3-6H5
Hostmouse
Antibody TypePrimary antibodies
NCBI Full Gene Namekeratin 7, keratin 19, keratin 8, keratin 18
NCBI Gene AliasesSCL, CK7, CARD2, K19, K18, KO, CYK8, K1CS, K2C7, K2C8, K7, CK8, CK-18, CK19, CK-8, K8, CYK18
Clonalitymonoclonal
TargetCytokeratin
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1)BMC CancerJune 23, 2023Tarek Al-Hammouri, Ricardo Almeida-Magana, Rachel Lawrence, Tom Duffy, Laura White, Edwina Burke, Sakunthala Kudahetti, Justin Collins, Prabhakar Rajan, Daniel Berney, et al.130–113-114), the epithelial marker Cytokeratin-Fluorescein Isothiocyanate (Miltenyi biotec cat no. 130–118-964), and the mesenchymal marker Vimentin-AlexaFluor 568 (abcam cat no. ab202504). Cellular DNA is identified

(2) Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell InteractionsFrontiers in ImmunologyMay 13, 2022Michael Eikmans, Carin van der Keur, Jacqueline D. H. Anholts, Jos J. M. Drabbels, Els van Beelen, Susana M. Chuva de Sousa Lopes, Marie-Louise van der Hoorn(mouse),PE,Biolegend,27-35,402204 ITGA1/CD49a,APC,BioLegend,TS2/7,328314 ITGA2/CD49b,APC,BioLegend,P1E6-C5,359309 ITGA2/CD49b,PE,BioLegend,P1E6-C5,359307 ITGA4/CD49d,PE,BioLegend,9F10,304303 ITGA5/CD49e,APC,BioLegend,NKI-SAM-1,328011 ITGA6/CD49f,PE,BioLegend,GoH3,313612 ITGB1/CD29,APC,BioLegend,TS2/16,303007 KRT,FITC,Miltenyi Biotec,CK-6H5,130-118-964 NOTCH1,APC,BioLegend,MHN1-519,352107 VIM,Alexa-647,BioLegend,O91D3,677807 Overview of antibodies

(3) Exchange of cellular components between platelets and tumor cells: impact on tumor cells behaviorTheranosticsFebruary 7, 2022Alba Rodriguez-Martinez et al.prostate cancer patients CTCs isolation and fixed cells were stained with mouse anti-human Cytokeratin-FITC (Ref. 130-119-141, Miltenyi), mouse anti-human CD61-Alexa Fluor 647 (Ref. 336408, Biolegend), and Hoechst 33342 (Thermo

(4) Detection of VAR2CSA-Captured Colorectal Cancer Cells from Blood Samples by Real-Time Reverse Transcription PCRCancers (Basel)November 23, 2021Sara R. Bang-Christensen, Viatcheslav Katerov, Amalie M. Jørgensen, Tobias Gustavsson, Swati Choudhary, Thor G. Theander, Ali Salanti, Hatim T. Allawi, Mette Ø. AgerbækCells were incubated with FITC-conjugated pan-CK antibody (Clone: CK3 6H5, dilution: 1:50, Cat. no. 130-118-964, Miltenyi Biotec, Lund, Sweden), PE-labelled anti-CD45 antibody (Clone: 5B1, dilution: 1:10, Cat. no.

(5) The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer PatientsCancers (Basel)March 5, 2021Ivonne Nel, Erik W. Morawetz, Dimitrij Tschodu, Josef A. Käs, Bahriye Aktasmin,Miltenyi and binding of primary antibodies (final concentration 20 µL/mL) with FITC-conjugated mouse anti-CK (130-118-964, Biotec, Germany) for 10 min at 25 °C. Then cells were washed in PBS containing 0.1% ◦ C. Then cells

(6) Mesenchymal stem cells negatively regulate CD4⁺ T cell activation in patients with primary Sjögren syndrome through the miRNA‑125b and miRNA‑155 TCR pathwayMolecular medicine reportsJanuary 1, 2021Gong B, Zheng L, Lu Z, Huang J, Pu J, Pan S, Zhang M, Liu J, Tang J.human albumin-FITC (cat. no. CLFAG2140; Cedarlane Laboratories) and pan-cytokeratin-FITC (cat. no. 130-119-141; Miltenyi Biotec GmbH), and then with secondary FITC rabbit anti-human albumin (cat. no. A18904; eBioscience;

(7) Establishment and characterization of 7 novel hepatocellular carcinoma cell lines from patient-derived tumor xenograftsPloS oneJanuary 1, 2014Xin H, Wang K, Hu G, Xie F, Ouyang K, Tang X, Wang M, Wen D, Zhu Y, Qin X.

(8) Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neckPloS oneJanuary 1, 2012Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA Jr, et al.

(9) Monoclonal antibody to cytokeratin for use in routine histopathologyJournal of clinical pathologySeptember 1, 1984Makin CA, Bobrow LG, Bodmer WF.

Be the First to Write a Review!

Cytokeratin Antibody, anti-human, FITC from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (9)

Reviews

Cytokeratin Antibody, anti-human, FITC from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map